KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Short-Term Debt repayments

Daily Values

Growth Metrics

Organon (OGN) Other financing activities (2020 - 2024)

Organon has reported Other financing activities over the past 3 years, most recently at $2.0 million for Q4 2024.

For Q4 2024, Other financing activities changed N/A year-over-year to $2.0 million; the TTM value through Dec 2025 reached $2.0 million, down 95.0%, while the annual FY2024 figure was $38.0 million, N/A changed from the prior year.
Other financing activities for Q4 2024 was $2.0 million at Organon, down from $38.0 million in the prior quarter.
Over five years, Other financing activities peaked at $474.0 million in Q3 2021 and troughed at -$244.0 million in Q1 2021.
A 3-year average of $17.6 million and a median of $2.0 million in 2024 define the central range for Other financing activities.
On a YoY basis, Other financing activities climbed as much as 1792.86% in 2021 and fell as far as 371.11% in 2021.
Year by year, Other financing activities stood at -$171.0 million in 2020, then soared by 377.19% to $474.0 million in 2021, then plummeted by 99.58% to $2.0 million in 2024.
Business Quant data shows Other financing activities for OGN at $2.0 million in Q4 2024, $38.0 million in Q2 2024, and $474.0 million in Q3 2021.